Topamax and Cataract - a phase IV clinical study of FDA data
Cataract is found among people who take Topamax, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Topamax and have Cataract. It is created by eHealthMe based on reports of 48,071 people who have side effects when taking Topamax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
48,071 people reported to have side effects when taking Topamax.
Among them, 235 people (0.49%) have Cataract.
What is Topamax?
Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 52,605 Topamax users for its effectiveness, alternative drugs and more.
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 2,442 drugs and 1,964 conditions by eHealthMe.
Number of Topamax and Cataract reports submitted per year:
Time on Topamax when people have Cataract *:
Gender of people who have Cataract when taking Topamax*:
Age of people who have Cataract when taking Topamax *:
Common drugs people take besides Topamax *:
Common side effects people have besides Cataract *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Topamax and have Cataract?Check whether Cataract is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Alternative drugs to, pros and cons of Topamax:
- Topamax (52,605 reports)
Cataract treatments and more:
- Cataract (53,455 reports)
COVID vaccines that are related to Cataract:
- Cataract in Moderna COVID Vaccine
- Cataract in Pfizer BioNTech Covid Vaccine
- Cataract in Johnson and Johnson Covid Vaccine
How severe was Cataract and when was it recovered:
Expand to all the drugs that have ingredients of topiramate:
- Cataract and drugs with ingredients of topiramate (373 reports)
Common drugs associated with Cataract:
All the drugs that are associated with Cataract:
- Cataract (2,442 drugs)
Common conditions associated with Cataract:
All the conditions that are associated with Cataract:
- Cataract (1,964 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on topiramate (the active ingredients of Topamax) and Topamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.